Medtronic Foundation launches new STEM partnerships to serve over 60,000 underserved and underrepresented students
Multi-year partnerships to serve over 60,000 underserved and underrepresented K-12 students in Minnesota, Northern California and Puerto Rico The partnerships address the root cause of persistent inequities by creating opportunity for economic advanceme... Devices Medtronic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 21, 2022 Category: Pharmaceuticals Source Type: news

GPX Embolic Device Success in Challenging Tumor Case
Fluidx Medical's Novel Embolic Device Demonstrates Repeated Success in Treating Complex Tumors SALT LAKE CITY, Jan. 20, 2022 -- (Healthcare Sales & Marketing Network) -- Fluidx Medical's GPX Embolic Device was used to effectively devascularize a large ... Devices, Interventional Fluidx Medical Technology, GPX Embolic Device (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 20, 2022 Category: Pharmaceuticals Source Type: news

BioTheryX Announces Appointment of Sahm Nasseri as Chief Business Officer
SAN DIEGO, Jan. 20, 2022 -- (Healthcare Sales & Marketing Network) -- BioTheryX, Inc., a clinical-stage company focused on targeted protein degradation to create life-saving medicines, today announced the appointment of Sahm Nasseri as Chief Business Offi... Biopharmaceuticals, Personnel BioTheryX, protein homeostasis, PRODEGY (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 20, 2022 Category: Pharmaceuticals Source Type: news

Alpha Tau Announces New Research Collaboration to Study the Potential of Alpha DaRT to Enhance Immune Stimulation in the Treatment of Breast Cancer
JERUSALEM, Jan. 20, 2022 -- (Healthcare Sales & Marketing Network) -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has signed a sponsored research agree... Devices, Oncology Alpha Tau Medical, Alpha DaRT (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 20, 2022 Category: Pharmaceuticals Source Type: news

Titan SGS(R) from Standard Bariatrics, Inc. Passes 1,000 Clinical Case Uses
CINCINNATI, Jan. 19, 2022 -- (Healthcare Sales & Marketing Network) -- Bariatric surgeons are seeing benefits delivered to patients from the anatomy-based approach of Titan SGS® surgical stapler technology from Standard Bariatrics®, Inc. Since the... Devices, Surgery Standard Bariatrics, Titan SGS, bariatric sleeve surgery, sleeve gastrectomy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2022 Category: Pharmaceuticals Source Type: news

Amber Implants Closes US$10 M Series A Financing
THE HAGUE, Netherlands, Jan. 19, 2022 -- (Healthcare Sales & Marketing Network) -- Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal injuries, today announces the successful closing of its US$10... Devices, Orthopaedic, Neurosurgery, Venture Capital Amber Implants, VCFix spinal system, vertebral fracture (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2022 Category: Pharmaceuticals Source Type: news

Smith and Nephew acquires novel cementless partial knee system
LONDON, Jan. 19, 2022 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (LSE: SN,NYSE: SNN), the global medical technology business, announces the acquisition of Engage Surgical, owner of the only cementless unicompartmental (partial) knee syste... Devices, Orthopaedic, Mergers & Acquisitions Smith & Nephew, Engage Surgical, cementless unicompartmental knee, partial knee (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 19, 2022 Category: Pharmaceuticals Source Type: news

Hip Innovation Technology Receives FDA Investigational Device Exemption (IDE) Approval to Initiate Landmark Study of its Reverse Hip Replacement System
HIT's Reverse Hip Replacement System may Revolutionize Total Hip Replacement Surgery BOCA RATON, Fla., Jan. 18, 2022 -- (Healthcare Sales & Marketing Network) -- Hip Innovation Technology, LLC (HIT), a medical device company developing innovative ortho... Devices, Orthopaedic, FDA Hip Innovation Technology, Reverse Hip Replacement (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2022 Category: Pharmaceuticals Source Type: news

CryoLife Announces Corporate Rebranding and Changes Name to Artivion
Artivion to Host Investor & Analyst Day on March 23, 2022 ATLANTA, Jan. 18, 2022 -- (Healthcare Sales & Marketing Network) -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it ... Devices, Cardiology CryoLife, Artivion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2022 Category: Pharmaceuticals Source Type: news

Endomina(R) System, a New Suturing Tool for Use by Gastroenterologists Receives FDA Clearance
Endo Tools Therapeutics proprietary platform offers competitive technology designed to enable less invasive procedures GOSSELIES, Belgium, Jan. 18, 2022 -- (Healthcare Sales & Marketing Network) -- Endo Tools Therapeutics (ETT), developers of advanced ... Devices, Gastroenterology, FDA Endo Tools Therapeutics, endomina (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2022 Category: Pharmaceuticals Source Type: news

Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials
Dermaliq Therapeutics, Inc. is an independent private pharmaceutical company emerged from Novaliq Spin-off to unlock value in the space of medical dermatology by using Novaliq's transformative technology outside eye care 3E Bioventures Capital and Be... Biopharmaceuticals, Dermatology, Venture Capital Dermaliq Therapeutics, alopecia, psoriasis, soft tissue infection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2022 Category: Pharmaceuticals Source Type: news

CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation
SHANGHAI and DURHAM, N.C., Jan. 17, 2022 -- (Healthcare Sales & Marketing Network) -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company mainly focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies an... Biopharmaceuticals, Personnel CARsgen Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 17, 2022 Category: Pharmaceuticals Source Type: news

Jens Lindberg takes office as CEO of Medivir on January 24
STOCKHOLM, Jan. 17, 2022 -- (Healthcare Sales & Marketing Network) -- Medivir AB (Nasdaq Stockholm: MVIR) today announced that Jens Lindberg will assume his position as CEO on January 24, 2022. Magnus Christensen, who has been interim CFO since the Annual... Biopharmaceuticals, Personnel Medivir AB (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 17, 2022 Category: Pharmaceuticals Source Type: news

Vanda Pharmaceuticals Settles HETLIOZ(R) Patent Litigation with MSN
WASHINGTON, Jan. 14, 2022 -- (Healthcare Sales & Marketing Network) -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it has entered into a License Agreement (the License Agreement) with MSN Pharmaceuticals Inc., MSN Laboratories Privat... Biopharmaceuticals, Litigation, Licensing, Generics Vanda Pharmaceuticals, MSN Pharmaceuticals, Impax Laboratories (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 14, 2022 Category: Pharmaceuticals Source Type: news

SK Life Science Announces FDA Clearance of IND Application for its Oncology Candidate, SKL27969, a PRMT5 Inhibitor for the Potential Treatment of Advanced Solid Tumors
Clearance of the IND application for SKL27969 marks the company's expansion into oncology PARAMUS, N.J., Jan. 13, 2022 -- (Healthcare Sales & Marketing Network) -- SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative gl... Biopharmaceuticals, Oncology, FDA SK Life Science, SK Biopharmaceuticals, solid tumors (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 13, 2022 Category: Pharmaceuticals Source Type: news

PANTHERx Rare(R) Selected by Xeris Pharmaceuticals to Distribute Recorlev(R) (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients with Cushing's Syndrome
PITTSBURGH, Jan. 13, 2022 -- (Healthcare Sales & Marketing Network) -- PANTHERx Rare announces that it has been selected by Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Xeris Biopharma Holdings, Inc., as the exclusive U.S. pharmacy distributi... Biopharmaceuticals, Distribution Xeris Pharmaceuticals, PANTHERx Rare, Recorlev, levoketoconazole, Cushing's (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 13, 2022 Category: Pharmaceuticals Source Type: news

Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms
EnSite™ X EP System with EnSite Omnipolar Technology (OT) provides a 360-degree view of the heart, regardless of catheter orientation, for cardiac mapping without compromise ABBOTT PARK, Ill., Jan. 12, 2022 -- (Healthcare Sales & Marketing Network) --... Devices, Interventional, Cardiology, FDA Abbott, EnSite X EP System, EnSite Omnipolar Technology, cardiac mapping (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 12, 2022 Category: Pharmaceuticals Source Type: news

DALI Medical's SAN(R)Light Passive Safety Needle coupled with a novel Drug Product, Enabling User-friendly Administration
TEL AVIV, Israel, Jan. 12, 2022 -- (Healthcare Sales & Marketing Network) -- DALI Medical Devices, an innovative developer and distributor of drug delivery devices, today announced the first commercial implementation of its SAN-Light passive safety needle... Devices, Drug Delivery, Product Launch DALI Medical Devices, SAN-Light, passive safety needle, DALI injector (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 12, 2022 Category: Pharmaceuticals Source Type: news

CBMG Receives FDA Regenerative Medicine Advanced Therapy and Fast Track Designations for Bi-Specific Anti-CD19/CD20 CAR-T Cell Therapy for Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
ROCKVILLE, Md., Jan. 12, 2022 -- (Healthcare Sales & Marketing Network) -- Cellular Biomedicine Group Inc. (CBMG or the "Company"), a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, today ann... Biopharmaceuticals, Regenerative Medicine, Oncology Cellular Biomedicine Group, CAR-T therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 12, 2022 Category: Pharmaceuticals Source Type: news

AliveCor Announces Strategic Additions to Executive Team
MOUNTAIN VIEW, Calif., Jan. 11, 2022 -- (Healthcare Sales & Marketing Network) -- AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced the addition of four new leaders to the company's executive team: Vin... Devices, Monitoring, Personnel AliveCor, KardiaMobile, ECG (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2022 Category: Pharmaceuticals Source Type: news

Vivera Appoints Donald D'Ambrosio as Chief Financial Officer
NEWPORT BEACH, Calif., Jan. 11, 2022 -- (Healthcare Sales & Marketing Network) -- Vivera Pharmaceuticals announced today, the appointment of Donald D'Ambrosio as the Company's Chief Financial Officer (CFO). With over four decades of experience serving ... Biopharmaceuticals, Drug Delivery, Personnel Vivera Pharmaceuticals, TABMELT, sublingual (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2022 Category: Pharmaceuticals Source Type: news

Nine Square Therapeutics Appoints Robert Paul as CEO
SOUTH SAN FRANCISCO, Calif., Jan. 11, 2022 -- (Healthcare Sales & Marketing Network) -- Nine Square Therapeutics, a biotechnology company applying computational chemistry and machine-learning enabled cell profiling to discover and develop novel small-mole... Biopharmaceuticals, Neurology, Personnel Nine Square Therapeutics, Parkinson's disease, amyotrophic lateral sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2022 Category: Pharmaceuticals Source Type: news

ACELYRIN Appoints Melanie Gloria as Chief Operating Officer
LOS ANGELES, Jan. 11, 2022 -- (Healthcare Sales & Marketing Network) -- ACELYRIN, INC., a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of ... Biopharmaceuticals, Personnel ACELYRIN (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2022 Category: Pharmaceuticals Source Type: news

New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities
2F XO Cross 14 Microcath platform successfully used in challenging peripheral vascular procedures. PARK CITY, Utah, Jan. 11, 2022 -- (Healthcare Sales & Marketing Network) -- Transit Scientific announced continued multicenter success with the XO Cross&... Devices, Interventional Transit Scientific, XO Cross, Microcatheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2022 Category: Pharmaceuticals Source Type: news

Endo Appoints Dr. James P. Tursi as Executive Vice President, Global Research and Development
DUBLIN, Jan. 11, 2022 -- (Healthcare Sales & Marketing Network) -- Endo International plc (NASDAQ: ENDP) today announced the appointment of Dr. James P. Tursi as Executive Vice President, Global Research & Development effective January 18, 2022. He will ... Biopharmaceuticals, Personnel Endo International (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2022 Category: Pharmaceuticals Source Type: news

Valo Health Names Dave Morris Chief Medical Officer
BOSTON, Jan. 10, 2022 -- (Healthcare Sales & Marketing Network) -- Valo Health, LLC ("Valo") announced today that Dave Morris, M.D., has been appointed Chief Medical Officer (CMO), Head of Therapeutics Research and Development. Morris has joined... Biopharmaceuticals, Personnel Valo Health, Opal Computational Platform (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 10, 2022 Category: Pharmaceuticals Source Type: news

Breakthrough in Device Therapy for Patients with Late-Stage Heart Disease
Calon Cardio-Technology Ltd. and Leviticus-Cardio Ltd. announce the joint Development and Testing of a Wireless, Fully Implantable, Long-Term Blood Pump. SWANSEA, Wales and TEL AVIV, Israel, Jan. 10, 2022 -- (Healthcare Sales & Marketing Network) -- Se... Devices, Cardiology Calon Cardio-Technology, Leviticus-Cardio, Calon Cardio MiniVAD, FiVAD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 10, 2022 Category: Pharmaceuticals Source Type: news

Alpha Tau Announces Results of First US Clinical Trial of Alpha DaRT(TM) in Malignant Skin and Soft Tissue Cancers, Showing Complete Response in All Ten Treated Tumors at Approximately 12 Weeks and No Product-Related Serious Adverse Events
JERUSALEM, Jan. 10, 2022 -- (Healthcare Sales & Marketing Network) -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that all ten patients in its US multi-center ... Devices, Oncology Alpha Tau Medical, Alpha DaRT (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 10, 2022 Category: Pharmaceuticals Source Type: news

Collagen Matrix, Inc. Names Tony Orsini Chief Operating Officer
OAKLAND, N.J., Jan. 7, 2022 -- (Healthcare Sales & Marketing Network) -- Collagen Matrix, Inc., a leader in regenerative medicine, global manufacturer of collagen- and mineral-based medical devices, and Linden Capital Partners portfolio company, announced... Devices, Regenerative Medicine, Personnel Collagen Matrix (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 7, 2022 Category: Pharmaceuticals Source Type: news

NICE recommends first smartphone-based ECG for the detection of atrial fibrillation (AF) for people with suspected paroxysmal AF in an ambulatory monitoring setting
AliveCor's KardiaMobile® is the only personal electrocardiogram (ECG) to be recommended by the National Institute for Health and Care Excellence (NICE) for use within the NHS[1] NICE's positive recommendation[1] offers patients and physicians across... Devices, Monitoring, Cardiology AliveCor , KardiaMobile, atrial fibrillation, electrocardiogram (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 7, 2022 Category: Pharmaceuticals Source Type: news

BIOLASE and EdgeEndo Announce FDA 510(k) Clearance of New EdgePRO Laser-Assisted Microfluidic Irrigation Device for Endodontists
The EdgePRO system offers a more effective, innovative cleaning and disinfection technology for the endodontic community FOOTHILL RANCH, Calif., Jan. 6, 2022 -- (Healthcare Sales & Marketing Network) -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader i... Devices, Dental, FDA BIOLASE, EdgeEndo, EdgePRO, Microfluidic Irrigation Device (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 6, 2022 Category: Pharmaceuticals Source Type: news

BlueWind Medical(TM) Ltd. Makes Key Additions to Leadership Team
PARK CITY, Utah and HERZLIYA, Israel, Jan. 6, 2022 -- (Healthcare Sales & Marketing Network) -- BlueWind Medical™, Ltd., developer of the innovative RENOVA™ iStim implantable neuromodulation device for treatment of Overactive Bladder, today announced addi... Devices, Urology, Personnel BlueWind Medical, RENOVA iStim, neuromodulation, Overactive Bladder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 6, 2022 Category: Pharmaceuticals Source Type: news

New Procedure to Revolutionise Paediatric Ear Surgery Performed for the First Time with AventaMed Solo + Tympanostomy Tube Device (TTD)
CORK, Ireland, Jan. 6, 2022 -- (Healthcare Sales & Marketing Network) -- AventaMed DAC, a developer of novel medical devices that streamline surgery, allowing procedures to move out of the operating theatre and into new sites of service such as the doctor... Devices AventaMed, Solo+ TTD, tympanostomy tube (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 6, 2022 Category: Pharmaceuticals Source Type: news

Meridian Bioscience Receives FDA Clearance for the Curian(R) Campy Assay
CINCINNATI, Jan. 5, 2022 -- (Healthcare Sales & Marketing Network) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that the Curian® Campy assay has ... Diagnostics, FDA Meridian Bioscience, Curian Campy assay, Campylobacter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 5, 2022 Category: Pharmaceuticals Source Type: news

Neuvivo Expands Management Team Adding Gregg Fergus, Former President of Ion Torrent, as Head of Strategy and Business Development and to the Board of Directors
Fergus Brings Track Record of Commercial, Operational and Fund-Raising Success to Company PALO ALTO, Calif., Jan. 5, 2022 -- (Healthcare Sales & Marketing Network) -- Neuvivo today announced the expansion of its management team and Board, adding Gregg ... Biopharmaceuticals, Neurology, Personnel Neuvivo, amyotrophic lateral sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 5, 2022 Category: Pharmaceuticals Source Type: news

Abbott's Proclaim(TM) XR Spinal Cord Stimulation System Now Offers Expanded MRI Compatibility in U.S.
New U.S. FDA-approved labeling lifts restrictions on 60-centimeter Octrode™ leads, which are implanted, electrically insulated wires that transmit electrical impulses to the target nerves Expanded MRI compatibility allows more patients to obtain necessa... Devices, Neurology, Radiology, FDA Abbott, Proclaim XR, Spinal Cord Stimulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2022 Category: Pharmaceuticals Source Type: news

Zynex Submits FDA Application for its Next Generation Fluid and Blood Volume Monitor
ENGLEWOOD, Colo., Jan. 3, 2022 -- (Healthcare Sales & Marketing Network) -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, ... Devices, Monitoring, FDA Zynex, CM-1600, fluid monitoring (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 3, 2022 Category: Pharmaceuticals Source Type: news

Curis Adds Three New Executives to Management Team Strengthening Medical Affairs, Clinical Development and Clinical Operations
Curis expands leadership with additions of Felix Geissler, M.D., Ph.D., as Vice President of Medical Affairs, Kimberly Steinmann, M.D., as Vice President of Clinical Development, and Dora Ferrari, as Vice President of Clinical Operations LEXINGTON, Mass... Biopharmaceuticals, Oncology, Personnel Curis, immuno-oncology, precision oncology, non-Hodgkin lymphoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 3, 2022 Category: Pharmaceuticals Source Type: news

Alpha Tau Announces Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head and Neck Cancer
JERUSALEM, Jan. 3, 2022 -- (Healthcare Sales & Marketing Network) -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has been notified by HekaBio K.K., its... Devices, Oncology Alpha Tau Medical, Alpha DaRT (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 3, 2022 Category: Pharmaceuticals Source Type: news

Biosion, Inc. Appoints Anthony Yeh, Ph.D., as Chief Strategy Officer and Head of China BD
NEWARK, Del. and NANJING, China, Jan. 3, 2022 -- (Healthcare Sales & Marketing Network) -- Biosion, Inc. ("Biosion"), a global clinical stage biotechnology company, today announced the appointment of Dr. Anthony Yeh to the position of Chief Stra... Biopharmaceuticals, Personnel Biosion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 3, 2022 Category: Pharmaceuticals Source Type: news

Bioretec Files for CE Mark for its Bioresorbable RemeOs Magnesium Screw in the EU
HELSINKI, Dec. 31, 2021 -- (Healthcare Sales & Marketing Network) -- Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, has submitted an application for the CE mark for the first product in its new RemeOs™ product family, the RemeOs™ trauma scr... Devices, Orthopaedic, Regulatory Bioretec, RemeOs, trauma screw, bioresorbable (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 31, 2021 Category: Pharmaceuticals Source Type: news

Amador Bioscience Announces the Completion of $60 Million Series B+ Round Financing
PLEASANTON, Calif., Dec. 30, 2021 -- (Healthcare Sales & Marketing Network) -- Amador Bioscience, a global translational sciences and clinical pharmacology CRO, announced today that it has completed 60MM USD Series B+ financing led by MSA Capital, a globa... Biopharmaceuticals, Venture Capital Amador Bioscience (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 30, 2021 Category: Pharmaceuticals Source Type: news

Blueprint Medicines Completes Acquisition of Lengo Therapeutics
Expands Blueprint Medicines' lung cancer pipeline with LNG-451, a highly selective brain-penetrant precision therapy targeting EGFR exon 20 insertion mutations Investigational New Drug application for LNG-451 submitted to U.S. FDA by Lengo Therapeutics ... Biopharmaceuticals, Mergers & Acquisitions Blueprint Medicines, Lengo Therapeutics, precision therapy, NSCLC (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 30, 2021 Category: Pharmaceuticals Source Type: news

MindMed Announces Transitions to Management Team
Bradford Cross, Chief Technology Officer to transition; Don Gehlert, PhD, Chief Scientific Officer to transition to Senior Scientific Advisor NEW YORK, Dec. 29, 2021 -- (Healthcare Sales & Marketing Network) -- Mind Medicine (MindMed) Inc. (NASDAQ: MNM... Biopharmaceuticals, Personnel Mind Medicine, MindMed, psychedelic medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 29, 2021 Category: Pharmaceuticals Source Type: news

Ionis and AstraZeneca close deal to develop and commercialize eplontersen
CARLSBAD, Calif., Dec. 29, 2021 -- (Healthcare Sales & Marketing Network) -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted therapies, today announced the closing of the collaboration agreement with AstraZeneca to develop and comme... Biopharmaceuticals Ionis Pharmaceuticals, AstraZeneca, eplontersen, transthyretin amyloidosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 29, 2021 Category: Pharmaceuticals Source Type: news

Petros Pharmaceuticals Announces Closing of $7.5 Million Offering
Investors included the company's largest shareholder NEW YORK, Dec. 28, 2021 Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced the closing of its previously announced registered direct offe... Biopharmaceuticals, Venture Capital Petros Pharmaceuticals, erectile dysfunction, endothelial dysfunction (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 28, 2021 Category: Pharmaceuticals Source Type: news

Nobel Biocare Receives FDA 510(k) Clearance for the Nobel Biocare N1(TM) Implant System
BREA, Calif., Dec. 27, 2021 -- (Healthcare Sales & Marketing Network) -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the U.S. Food and Drug Administration (FDA) has cleared the Nobel Biocare N1™ implant system. Boa... Devices, Dental, FDA Nobel Biocare, Envista, N1 implant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 27, 2021 Category: Pharmaceuticals Source Type: news

VLP Therapeutics raises $21M Series A-1 for cancer treatment vaccine, infectious diseases vaccine RandD
GAITHERSBURG, Md., Dec. 27, 2021 -- (Healthcare Sales & Marketing Network) -- US-based biotech company VLP Therapeutics, Inc. (VLPT) announced on December 27 that it has signed an agreement for an investment of US$21 million in a Series A-1 round from six... Biopharmaceuticals, Venture Capital VLP Therapeutics, vaccine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 27, 2021 Category: Pharmaceuticals Source Type: news

FDA Authorizes Further NurOwn(R) Dosing Under Expanded Access Program
Three additional doses of NurOwn® will be made available to participants who completed the Expanded Access Protocol FDA approved EAP manufacturing at the Catalent Texas site NEW YORK, Dec. 27, 2021 -- (Healthcare Sales & Marketing Network) -- Br... Regenerative Medicine, Neurology, FDA BrainStorm Cell Therapeutics, NurOwn, amyotrophic lateral sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 27, 2021 Category: Pharmaceuticals Source Type: news

Rhaeos, Inc. Raises $2.2 Million in Oversubscribed Seed Round
EVANSTON, Ill., Dec. 24, 2021 -- (Healthcare Sales & Marketing Network) -- Rhaeos, Inc., a private, clinical stage medical device company developing a platform wireless and non-invasive wearable sensor initially targeting the neurosurgical suite, today an... Devices, Monitoring, Neurosurgery, Venture Capital Rhaeos , FlowSense, hydrocephalus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 24, 2021 Category: Pharmaceuticals Source Type: news